- Home
- INSG vs OPTN Comparison
INSG vs OPTN Comparison
Compare INSG & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSG
- OPTN
- Stock Information
- Founded
- INSG 1996
- OPTN 2010
- Country
- INSG United States
- OPTN United States
- Employees
- INSG N/A
- OPTN N/A
- Industry
- INSG Telecommunications Equipment
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- INSG Telecommunications
- OPTN Health Care
- Exchange
- INSG Nasdaq
- OPTN Nasdaq
- Market Cap
- INSG 111.5M
- OPTN 92.8M
- IPO Year
- INSG 2000
- OPTN 2017
- Fundamental
- Price
- INSG $8.48
- OPTN $9.39
- Analyst Decision
- INSG Buy
- OPTN Hold
- Analyst Count
- INSG 3
- OPTN 3
- Target Price
- INSG $13.00
- OPTN $9.00
- AVG Volume (30 Days)
- INSG 87.2K
- OPTN 41.7K
- Earning Date
- INSG 05-08-2025
- OPTN 05-20-2025
- Dividend Yield
- INSG N/A
- OPTN N/A
- EPS Growth
- INSG N/A
- OPTN N/A
- EPS
- INSG 0.10
- OPTN N/A
- Revenue
- INSG $191,244,000.00
- OPTN $78,226,000.00
- Revenue This Year
- INSG $2.53
- OPTN $30.49
- Revenue Next Year
- INSG $11.55
- OPTN $13.51
- P/E Ratio
- INSG $81.58
- OPTN N/A
- Revenue Growth
- INSG 14.32
- OPTN 10.20
- 52 Week Low
- INSG $3.70
- OPTN $4.82
- 52 Week High
- INSG $20.67
- OPTN $20.03
- Technical
- Relative Strength Index (RSI)
- INSG 53.95
- OPTN 76.15
- Support Level
- INSG $8.00
- OPTN $9.14
- Resistance Level
- INSG $8.60
- OPTN $9.45
- Average True Range (ATR)
- INSG 0.44
- OPTN 0.08
- MACD
- INSG 0.13
- OPTN -0.07
- Stochastic Oscillator
- INSG 81.16
- OPTN 80.71
About INSG Inseego Corp.
Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.